Human Milk Oligosaccharides (HMO) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Sarasota, FL -- (SBWire) -- 02/20/2019 --Global Human Milk Oligosaccharides (HMO) Market: Overview

Human milk oligosaccharides (HMO) is present in human milk in the form of a complex bioactive sugar molecule. HMOs are growth substrates for certain useful bacteria. Extracting or synthesizing HMO in the formula is quite difficult as they are structurally diverse and complex. The human milk oligosaccharides (HMO) products available in the market are quite expensive as a huge quantity of human milk is synthesized just to obtain a small amount of HMO.

Global Human Milk Oligosaccharides (HMO) Market: Growth Factors

Addition of HMO in functional food products and beverages has benefits such as it encourages the growth of good bacteria and reduces unsafe bacteria such as listeria, salmonella, and campylobacter. Due to the prebiotic functions and the antimicrobial protection of HMOs, they are increasingly used as a useful ingredient in products such as medicinal food, pharmaceutical, and infant formulas, thus driving the growth of the human milk oligosaccharides (HMO) market. Major application segment of HMO is infant formula. Since infant formulas improve the brain development and enhance memory power the market is anticipated to witness significant growth in the years to come. Major market players are increasingly investing in the R&D activities in order to improve their product portfolio, which is also contributing to the human milk oligosaccharides (HMO) market growth. On the other hand, the increased capital requirement for R&D activities is restricting the new market entrants. Moreover, the amount of HMO production is also limited as chemical synthesis of HMO is complicated owing to the existence of a number of hydroxyl groups having the same chemical reactivity.

Download Free PDF Research Report Brochure @ https://www.zionmarketresearch.com/requestbrochure/human-milk-oligosaccharides-market

Global Human Milk Oligosaccharides (HMO) Market: Segmentation

The human milk oligosaccharides (HMO) market is segmented based on its product, type, and applications. Based on the product, the market is segregated into 3'SL, 6'SL, 2'FL, and 3'FL. In terms of type, the global human milk oligosaccharides (HMO) market is fragmented into acidic, neutral, and others. On the basis of application, the market is divided into food supplements, food and beverages, infant formulas, and others.

Global Human Milk Oligosaccharides (HMO) Market: Regional Analysis

Majority of the market shares for human milk oligosaccharides is expected to be held by North America. North America has registered an increased demand for donor human milk. On the other hand, there exist only 11 milk banks in countries such as Canada and the U.S., which is actually not sufficient to meet the increasing demand for donor milk. This factor will increase the usage of HMO in the infant formula in order to provide proper nutrition to the babies. The Asia Pacific is also expected to grow in the coming years. The emerging economies, China and India are the developing markets for baby foods and dietary supplements. The UK, in Europe, has registered the lowest rate for breastfeeding. This is due to the increasing rate of working women population and cuts in public health funding. Thus, this region anticipates showing significant demand for HMO based products.

Get Free Sample Report of Keyword @ https://www.zionmarketresearch.com/sample/human-milk-oligosaccharides-market

Global Human Milk Oligosaccharides (HMO) Market: Competitive Players

Some of the major players involved in the human milk oligosaccharides (HMO) market include Jennewein Biotechnologie GmbH, Glycom A/S, Medolac Laboratories, Inbiose, Elicityl SA, ZuChem, Inc., and Glycosyn LLC.

Global Human Milk Oligosaccharides (HMO) Market: Regional Segment Analysis

North America
The U.S.
Europe
The UK
France
Germany
The Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa